Your browser doesn't support javascript.
loading
Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease.
Fournier, Emmanuelle; Selegny, Maëlle; Amsallem, Myriam; Haddad, Francois; Cohen, Sarah; Valdeolmillos, Estibaliz; Le Pavec, Jérôme; Humbert, Marc; Isorni, Marc-Antoine; Azarine, Arshid; Sitbon, Olivier; Jais, Xavier; Savale, Laurent; Montani, David; Fadel, Elie; Zoghbi, Joy; Belli, Emre; Hascoët, Sebastien.
Afiliação
  • Fournier E; Division of Congenital Heart Diseases, Expert Center for Complex Congenital Heart Disease (M3C Network), Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Le Plessis Robinson, France.
  • Selegny M; Division of Congenital Heart Diseases, Expert Center for Complex Congenital Heart Disease (M3C Network), Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Le Plessis Robinson, France; Pediatric and Congenital Cardiology Unit, University Hospital of Amiens, A
  • Amsallem M; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, United States.
  • Haddad F; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, United States.
  • Cohen S; Division of Congenital Heart Diseases, Expert Center for Complex Congenital Heart Disease (M3C Network), Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Le Plessis Robinson, France.
  • Valdeolmillos E; Division of Congenital Heart Diseases, Expert Center for Complex Congenital Heart Disease (M3C Network), Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Le Plessis Robinson, France; Institut national de la santé et de la recherche médicale (INSERM) Unite M
  • Le Pavec J; Division of Thoracic Surgery and Pneumology, Marie Lannelongue Hospital, Le Plessis Robinson, France.
  • Humbert M; Institut national de la santé et de la recherche médicale (INSERM) Unite Mixte de Recherche UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis-Robinson, France; Université Paris-Saclay, AP-HP, Department of Respiratory and Intensive Care Me
  • Isorni MA; Department of Radiology, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Le Plessis Robinson, France.
  • Azarine A; Department of Radiology, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Le Plessis Robinson, France.
  • Sitbon O; Institut national de la santé et de la recherche médicale (INSERM) Unite Mixte de Recherche UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis-Robinson, France; Université Paris-Saclay, AP-HP, Department of Respiratory and Intensive Care Me
  • Jais X; Institut national de la santé et de la recherche médicale (INSERM) Unite Mixte de Recherche UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis-Robinson, France; Université Paris-Saclay, AP-HP, Department of Respiratory and Intensive Care Me
  • Savale L; Institut national de la santé et de la recherche médicale (INSERM) Unite Mixte de Recherche UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis-Robinson, France; Université Paris-Saclay, AP-HP, Department of Respiratory and Intensive Care Me
  • Montani D; Institut national de la santé et de la recherche médicale (INSERM) Unite Mixte de Recherche UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis-Robinson, France; Université Paris-Saclay, AP-HP, Department of Respiratory and Intensive Care Me
  • Fadel E; Institut national de la santé et de la recherche médicale (INSERM) Unite Mixte de Recherche UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis-Robinson, France; Division of Thoracic Surgery and Pneumology, Marie Lannelongue Hospital, Le Ple
  • Zoghbi J; Division of Congenital Heart Diseases, Expert Center for Complex Congenital Heart Disease (M3C Network), Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Le Plessis Robinson, France.
  • Belli E; Division of Congenital Heart Diseases, Expert Center for Complex Congenital Heart Disease (M3C Network), Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Le Plessis Robinson, France.
  • Hascoët S; Division of Congenital Heart Diseases, Expert Center for Complex Congenital Heart Disease (M3C Network), Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Le Plessis Robinson, France; Institut national de la santé et de la recherche médicale (INSERM) Unite M
Rev Esp Cardiol (Engl Ed) ; 76(5): 333-343, 2023 May.
Article em En, Es | MEDLINE | ID: mdl-35940550
ABSTRACT
INTRODUCTION AND

OBJECTIVES:

Outcome in patients with congenital heart diseases and pulmonary arterial hypertension (PAH) is closely related to right ventricular (RV) function. Two-dimensional echocardiographic parameters, such as strain imaging or RV end-systolic remodeling index (RVESRI) have emerged to quantify RV function.

METHODS:

We prospectively studied 30 patients aged 48±12 years with pretricuspid shunt and PAH and investigated the accuracy of multiple echocardiographic parameters of RV function (tricuspid annular plane systolic excursion, tricuspid annular peak systolic velocity, RV systolic-to-diastolic duration ratio, right atrial area, RV fractional area change, RV global longitudinal strain and RVESRI) to RV ejection fraction measured by cardiac magnetic resonance.

RESULTS:

RV ejection fraction <45% was observed in 13 patients (43.3%). RV global longitudinal strain (ρ [Spearman's correlation coefficient]=-0.75; P=.001; R2=0.58; P=.001), right atrium area (ρ=-0.74; P <.0001; R2=0.56; P <.0001), RVESRI (ρ=-0.64; P <.0001; R2=0.47; P <.0001), systolic-to-diastolic duration ratio (ρ=-0.62; P=.0004; R2=0.47; P <.0001) and RV fractional area change (ρ=0.48; P=.01; R2=0.37; P <.0001) were correlated with RV ejection fraction. RV global longitudinal strain, RVESRI and right atrium area predicted RV ejection fraction <45% with the greatest area under curve (0.88; 95%CI, 0.71-1.00; 0.88; 95%CI, 0.76-1.00, and 0.89; 95%CI, 0.77-1.00, respectively). RV global longitudinal strain >-16%, RVESRI ≥ 1.7 and right atrial area ≥ 22 cm2 predicted RV ejection fraction <45% with a sensitivity and specificity of 87.5% and 85.7%; 76.9% and 88.3%; 92.3% and 82.4%, respectively.

CONCLUSIONS:

RVESRI, right atrial area and RV global longitudinal strain are strong markers of RV dysfunction in patients with pretricuspid shunt and PAH.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Disfunção Ventricular Direita / Hipertensão Arterial Pulmonar / Cardiopatias Congênitas / Hipertensão Pulmonar Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En / Es Revista: Rev Esp Cardiol (Engl Ed) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Disfunção Ventricular Direita / Hipertensão Arterial Pulmonar / Cardiopatias Congênitas / Hipertensão Pulmonar Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En / Es Revista: Rev Esp Cardiol (Engl Ed) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França